ARTICLE | Financial News
Exact sells IPO
January 30, 2001 8:00 AM UTC
EXAS raised $56 million through the sale of 4 million shares at $14 in its IPO underwritten by Merrill Lynch; CIBC World Markets; and Thomas Weisel. The company, which uses genomics to develop cancer ...